---
title: "Neumora Therapeutics appoints Paul Berns as CEO"
date: "2025-02-13 15:13:57"
summary: "Neumora Therapeutics (NASDAQ:NMRA) said its co-founder and executive chair, Paul Berns, will transition to CEO and chair of the board. The firm added Henry Gosebruch will be leaving the company. NMRA said Michael Milligan will serve as chief financial officer. The company said Joshua Pinto will serve as president, and..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Neumora Therapeutics (NASDAQ:[NMRA](https://seekingalpha.com/symbol/NMRA "Neumora Therapeutics, Inc.")) said its co-founder and executive chair, [Paul Berns](https://seekingalpha.com/pr/20001181-neumora-therapeutics-announces-leadership-transition "Paul Berns"), will transition to CEO and chair of the board.
* The firm added Henry Gosebruch will be leaving the company.
* NMRA said Michael Milligan will serve as chief financial officer.
* The company said Joshua Pinto will serve as president, and Bill Aurora will serve as chief operating and development officer.

[seekalpha](https://seekingalpha.com/news/4407587-neumora-therapeutics-appoints-paul-berns-as-ceo)
